CLASS II ONGOING Device recall · Reported 12 Aug 2026 · FDA Enforcement Report

Merge OrthoPACS, medical imaging diagnostic workstation recalled

Merge Healthcare is recalling Merge OrthoPACS, medical imaging diagnostic workstation, distributed nationwide in the US. The recall was initiated on 30 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI (01)00842000101154(10)9.4.0.P02(11)260302, with Affected Versions: 9.4, 9.4 P01, and 9.4 P02.
Quantity recalled5 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2875-2026
FDA event ID
99391
Recalling firm
Merge Healthcare, Hartland, WI
Classification
Class II
Status
Ongoing
Recall initiated
30 Jun 2026
FDA classified
4 Aug 2026
Reported
12 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

30 Jun 2026Recall initiated by company
4 Aug 2026Classified by FDA+35 days
12 Aug 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Thumbnails from a previously opened patient study may be displayed in the Thumbnail Bar while a different patient study is currently open.

Product as listed by the FDA

Merge OrthoPACS, medical imaging diagnostic workstation

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Canada, and UK.

Nationwide

Questions about this recall

Is Merge OrthoPACS, medical imaging diagnostic workstation recalled?

Yes. Merge Healthcare recalled Merge OrthoPACS, medical imaging diagnostic workstation on 30 Jun 2026. The recall is Class II and its status is Ongoing. Recall number Z-2875-2026.

Why was it recalled?

Thumbnails from a previously opened patient study may be displayed in the Thumbnail Bar while a different patient study is currently open.

Which lots are affected?

UDI/DI (01)00842000101154(10)9.4.0.P02(11)260302, with Affected Versions: 9.4, 9.4 P01, and 9.4 P02.

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Canada, and UK.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Merge Healthcare

All 96

Other Imaging Equipment recalls

All 2,336